SOX plus PD-1 inhibitor
Sponsors
Chinese PLA General Hospital, Liaoning Cancer Hospital & Institute
Conditions
ChemotherapyGastric / Gastroesophageal Junction AdenocarcinomaGastric CancerImmunotherapyTumor Microenvironment
Phase 4
Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer
Not yet recruitingNCT07132528
Start: 2025-08-31End: 2028-09-30Target: 1000Updated: 2025-08-20
Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical Surgery
Not yet recruitingNCT07149181
Start: 2025-08-31End: 2028-09-30Target: 1000Updated: 2025-08-29
Comparing the Efficacy and Safety of Different Postoperative Adjuvant Regimens in Patients With Resectable Adenocarcinoma of the Esophagogastric Junction Who Underwent Radical Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy and Achieved pCR in Postoperative Pathology
Not yet recruitingNCT07161453
Start: 2025-09-30End: 2027-12-31Target: 500Updated: 2025-09-08